Holen Sie sich die Stockscreener-App
15.52
2.27%
-0.38
Schlusskurs vom Vortag:
$15.90
Offen:
$15.92
24-Stunden-Volumen:
170.46K
Relative Volume:
0.45
Marktkapitalisierung:
$722.66M
Einnahmen:
$502.79M
Nettoeinkommen (Verlust:
$23.71M
KGV:
31.04
EPS:
0.5
Netto-Cashflow:
$6.35M
1W Leistung:
-2.33%
1M Leistung:
-16.27%
6M Leistung:
+25.52%
1J Leistung:
+5.71%
1-Tages-Spanne:
$15.46
$16.08
1-Wochen-Bereich:
$15.33
$16.65
52-Wochen-Spanne:
$9.72
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Compare CLB vs SLB, BKR, HAL, TS, FTI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
15.52 | 740.36M | 502.79M | 23.71M | 6.35M | 0.50 |
|
SLB
Slb Ltd
|
44.35 | 66.89B | 35.69B | 3.45B | 4.54B | 2.3617 |
|
BKR
Baker Hughes Company
|
54.62 | 55.24B | 27.73B | 2.62B | 2.54B | 2.605 |
|
HAL
Halliburton Co
|
34.16 | 29.18B | 22.18B | 1.29B | 1.67B | 1.5088 |
|
TS
Tenaris S A Adr
|
52.60 | 27.01B | 12.00B | 1.98B | 2.02B | 2.7949 |
|
FTI
Technipfmc Plc
|
62.92 | 25.01B | 9.93B | 967.10M | 1.45B | 2.3076 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
CORE LABORATORIES' SECOND QUARTER 2022 WEBCAST AT 7:30 A.M. CDT / 2:30 P.M. CEST ON JULY 28, 2022 - Nasdaq
ProPetro (PUMP) Jumps 9.9%: Does the Stock Have More Room to Grow? - Bitget
Core Laboratories (NYSE:CLB) Shares Cross Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Core Laboratories Inc. (CLB) gains on sequential revenue growth and Solintec acquisition - MSN
Will Core Laboratories Inc. stock benefit from upcoming earnings reportsMarket Weekly Review & Fast Moving Stock Trade Plans - Naître et grandir
Core Laboratories (CLB) Gains on Sequential Revenue Growth and Solintec Acquisition - Yahoo Finance
Why Is Core Laboratories (CLB) Down 14.2% Since Last Earnings Report? - Yahoo Finance
Core Laboratories Eases Shareholder Threshold for Major Deals - TipRanks
Royce & Associates LP Has $5.44 Million Holdings in Core Laboratories Inc. $CLB - MarketBeat
Core Laboratories Delays 2025 Annual 10-K Filing - TipRanks
Core Laboratories (CLB) delays 2025 10-K amid international tax, control review - Stock Titan
CLB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Q1 EPS Forecast for Core Laboratories Lifted by Analyst - Defense World
Zacks Research Issues Optimistic Forecast for CLB Earnings - MarketBeat
CLB (Core Laboratories) ROC % : 5.95% (As of Dec. 2025) - GuruFocus
Core Laboratories (NYSE:CLB) Shares Surge Past Key Trend Line Nyse Composite Today - Kalkine Media
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving Average – Here’s Why - Defense World
Is Core Laboratories Inc. stock worth buying before Fed action2025 Retail Activity & Low Risk High Win Rate Stock Picks - mfd.ru
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2024 EARNIN - GuruFocus
Core Labs Jumps 79% in 6 Months: Time to Buy or Stay on the Sidelines? - Finviz
Core Laboratories (CLB) grants 7,526 performance share units to CAO Teo Sow Hang - Stock Titan
[Form 4] Core Laboratories Inc. /DE/ Insider Trading Activity - Stock Titan
Is Core Laboratories Inc. stock safe for risk averse investorsJuly 2025 Action & Free High Accuracy Swing Entry Alerts - mfd.ru
Will Core Laboratories Inc. stock recover faster than peersJuly 2025 Macro Moves & Verified Momentum Stock Ideas - mfd.ru
Core Laboratories (NYSE:CLB) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
Will Core Laboratories Inc. stock keep outperforming rivalsM&A Rumor & Short-Term Swing Trade Alerts - mfd.ru
Core Laboratories : Lab Celebrates 90 Years of Innovation, Insights & Impact - marketscreener.com
Can Core Laboratories Inc stock outperform in a bear marketTrade Ideas & Long-Term Capital Growth Ideas - baoquankhu1.vn
Core Laboratories Inc.: - marketscreener.com
Can Core Laboratories Inc. benefit from deglobalizationJuly 2025 Summary & Free Real-Time Volume Trigger Notifications - mfd.ru
Core Laboratories Q4 Earnings Call Highlights - Defense World
Core Laboratories outlines Q1 2026 guidance of $124M–$130M revenue amid strong international demand and cost challenges - MSN
Core Laboratories N.V. (NYSE:CLB) Q4 2025 Earnings Call Transcript - Insider Monkey
Core Laboratories Q4 Earnings Beat Estimates, Expenses Increase Y/Y - TradingView
Core Laboratories to Announce Q4 Earnings on February 4 - Intellectia AI
Core Laboratories Stock Under Pressure: Is This Energy Services Veteran a Contrarian Buy or a Value - AD HOC NEWS
Core Laboratories (NYSE:CLB) Shares Down 12%Here's Why - MarketBeat
Core Lab (CLB) Q4 2025 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Core Laboratories Q4 2025 earnings miss forecasts By Investing.com - Investing.com Canada
Core Laboratories Inc. (NYSE:CLB) Declares Quarterly Dividend of $0.01 - MarketBeat
Core Laboratories Stock Finds Its Footing: Modest Rebound Amid Cautious Energy Sentiment - AD HOC NEWS
Core Laboratories Inc (CLB) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Market ... By GuruFocus - Investing.com Canada
Core Laboratories (CLB) Anticipates Q1 Revenue Between $124M and $130M - GuruFocus
Core Laboratories (CLB) Exceeds Revenue Expectations in Q4, Boos - GuruFocus
Core Laboratories (NYSE:CLB) Announces Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Core Laboratories (CLB) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Core Laboratories: Fourth Quarter Earnings Overview - Bitget
Core Laboratories: Q4 Earnings Snapshot - KTEN
Core Laboratories (NYSE:CLB) Releases Q1 2026 Earnings Guidance - MarketBeat
Core Laboratories expects Q1 rev between $124 mln to $130 mln - marketscreener.com
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):